TEK c.2626C>T ;(p.L876F)

Variant ID: 9-27209169-C-T

NM_000459.3(TEK):c.2626C>T;(p.L876F)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.

Oncogene
Ehsani, Marzieh M; Bartsch, Sophie S; Rasa, Seyed Mohammad Mahdi SMM; Dittmann, Jessica J; Pungsrinont, Thanakorn T; Neubert, Laura L; Huettner, Soeren S SS; Kotolloshi, Roland R; Schindler, Katrin K; Ahmad, Aya A; Mosig, Alexander S AS; Adam, Lisa L; Ori, Alessandro A; Neri, Francesco F; Berndt, Alexander A; Grimm, Marc-Oliver MO; Baniahmad, Aria A
Publication Date: 2022-06

Variant appearance in text: TIE2: L876F
PubMed Link: 35513564
Variant Present in the following documents:
  • 41388_2022_Article_2333.pdf
View BVdb publication page



Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

Nature Communications
Lauss, Martin M; Donia, Marco M; Harbst, Katja K; Andersen, Rikke R; Mitra, Shamik S; Rosengren, Frida F; Salim, Maryem M; Vallon-Christersson, Johan J; Törngren, Therese T; Kvist, Anders A; Ringnér, Markus M; Svane, Inge Marie IM; Jönsson, Göran G
Publication Date: 2017-11-23

Variant appearance in text: TEK: 2626C>T; L876F
PubMed Link: 29170503
Variant Present in the following documents:
  • 41467_2017_1460_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page